30
Jul 2026
Researchers linked 129,136 global human and swine Salmonella genomes with sampling from a Guangdong pork supply chain to examine how downstream stages relate to antimicrobial resistance. The study suggests slaughterhouse and retail interfaces may concentrate S. 4,[5],12:i:- ST34, resistant strains, and mobile resistance elements, supporting broader One Health surveillance beyond farms.
30
Jul 2026
A ten-year study of residents of the city of São Paulo, Brazil, revealed that leisure-time physical activity is highly unequal and that the gap between social strata is widening.
30
Jul 2026
Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in the nonhuman primate model of HIV/AIDS.
30
Jul 2026
Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure (sustained HBsAg loss).
30
Jul 2026
It's typical for someone looking for relief from dry, itchy, red and irritated skin – also known as eczema or atopic dermatitis – to turn to common allergy medications called antihistamines.
30
Jul 2026
UC Berkeley researchers have identified regions of DNA that humans inherited from two unknown ancestors as a result of long-ago interbreeding among modern humans and at least four other archaic human relatives.
30
Jul 2026
While artificial intelligence (AI) holds immense promise for transforming health care for older adults, a new study published in JMIR Aging reveals significant friction between those who use AI health tools and those who create and fund them.
30
Jul 2026
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery for patients with high-risk, early-stage HER2-negative breast cancer, according to phase 2 clinical trial results from the ongoing I-SPY2 clinical trial platform.
30
Jul 2026
A joint research team led by Professor Daesik Kim (Department of Medicine, Sungkyunkwan University), along with Professor Yong-Sub Kim (University of Ulsan College of Medicine) and Professor Jae-Hyun Park (Sungkyunkwan University School of Medicine), has announced the development of 'OpenABE' (Open Adenine Base Editor).
30
Jul 2026
Cardiovascular disease (CVD) is among the leading causes of death worldwide. In South Korea, it is the second leading cause of death, and its incidence has continued to rise in recent years.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
